These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

345 related items for PubMed ID: 21880044

  • 81. Rapid controlled thawing of fresh-frozen plasma in a modified microwave oven.
    Rock G, Tackaberry ES, Dunn JG, Kashyap S.
    Transfusion; 1984; 24(1):60-5. PubMed ID: 6695440
    [Abstract] [Full Text] [Related]

  • 82. Impact of storage temperature and processing delays on cord blood quality: discrepancy between functional in vitro and in vivo assays.
    Louis I, Wagner E, Dieng MM, Morin H, Champagne MA, Haddad E.
    Transfusion; 2012 Nov; 52(11):2401-5. PubMed ID: 22500587
    [Abstract] [Full Text] [Related]

  • 83. An ex vivo evaluation of efficacy of refrigerated canine plasma.
    Grochowsky AR, Rozanski EA, de Laforcade AM, Sharp CR, Meola DM, Schavone JJ, Brooks MB.
    J Vet Emerg Crit Care (San Antonio); 2014 Nov; 24(4):388-97. PubMed ID: 25039603
    [Abstract] [Full Text] [Related]

  • 84. A study of the quantity of some stable and labile coagulation factors in fresh-frozen plasma produced from whole blood stored for 24 hours in Iran.
    Naghadeh HT, Roudkenar MH.
    Blood Transfus; 2009 Jan; 7(1):39-42. PubMed ID: 19290079
    [Abstract] [Full Text] [Related]

  • 85. Postfiltration factor VIII and fibrinogen levels in cryoprecipitate stored at room temperature and at 1 to 6 degrees C.
    Spivey MA, Jeter EK, Lazarchick J, Kizer J, Spivey LB.
    Transfusion; 1992 May; 32(4):340-3. PubMed ID: 1585439
    [Abstract] [Full Text] [Related]

  • 86. Multiple levels of degradation diminish hemostatic potential of thawed plasma.
    Matijevic N, Kostousov V, Wang YW, Wade CE, Wang W, Letourneau P, Hartwell E, Kozar R, Ko T, Holcomb JB.
    J Trauma; 2011 Jan; 70(1):71-9; discussion 79-80. PubMed ID: 21217484
    [Abstract] [Full Text] [Related]

  • 87. Proteomic characterization of freeze-dried human plasma: providing treatment of bleeding disorders without the need for a cold chain.
    Steil L, Thiele T, Hammer E, Bux J, Kalus M, Völker U, Greinacher A.
    Transfusion; 2008 Nov; 48(11):2356-63. PubMed ID: 18657073
    [Abstract] [Full Text] [Related]

  • 88. New approach to improving endothelial preservation in cryopreserved arterial substitutes.
    Pascual G, Rodríguez M, Corrales C, Turégano F, García-Honduvilla N, Bellón JM, Buján J.
    Cryobiology; 2004 Feb; 48(1):62-71. PubMed ID: 14969683
    [Abstract] [Full Text] [Related]

  • 89. Vitamin K-dependent coagulation factors and fibrinogen levels in FFP remain stable upon repeated freezing and thawing.
    Ben-Tal O, Zwang E, Eichel R, Badalbev T, Hareuveni M.
    Transfusion; 2003 Jul; 43(7):873-7. PubMed ID: 12823746
    [Abstract] [Full Text] [Related]

  • 90. Pathogen-reduction systems for blood components: the current position and future trends.
    Seghatchian J, de Sousa G.
    Transfus Apher Sci; 2006 Dec; 35(3):189-96. PubMed ID: 17110168
    [Abstract] [Full Text] [Related]

  • 91. Clinical tolerance of methylene blue virus-inactivated plasma. A randomized crossover trial in 12 healthy human volunteers.
    Simonsen AC, Sørensen H.
    Vox Sang; 1999 Dec; 77(4):210-7. PubMed ID: 10717600
    [Abstract] [Full Text] [Related]

  • 92. Implementation of the INTERCEPT Blood System for Platelets into routine blood bank manufacturing procedures: evaluation of apheresis platelets.
    Janetzko K, Lin L, Eichler H, Mayaudon V, Flament J, Klüter H.
    Vox Sang; 2004 May; 86(4):239-45. PubMed ID: 15144528
    [Abstract] [Full Text] [Related]

  • 93. Solvent-detergent filtered (S/D-F) fresh frozen plasma and cryoprecipitate minipools prepared in a newly designed integral disposable processing bag system.
    El-Ekiaby M, Sayed MA, Caron C, Burnouf S, El-Sharkawy N, Goubran H, Radosevich M, Goudemand J, Blum D, de Melo L, Soulié V, Adam J, Burnouf T.
    Transfus Med; 2010 Feb; 20(1):48-61. PubMed ID: 19778318
    [Abstract] [Full Text] [Related]

  • 94. Two pathogen reduction technologies--methylene blue plus light and shortwave ultraviolet light--effectively inactivate hepatitis C virus in blood products.
    Steinmann E, Gravemann U, Friesland M, Doerrbecker J, Müller TH, Pietschmann T, Seltsam A.
    Transfusion; 2013 May; 53(5):1010-8. PubMed ID: 22905868
    [Abstract] [Full Text] [Related]

  • 95.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 96. Extending the post-thaw viability of cryoprecipitate.
    Thomson C, Sobieraj-Teague M, Scott D, Duncan E, Abraham S, Roxby D.
    Transfusion; 2021 May; 61(5):1578-1585. PubMed ID: 33728705
    [Abstract] [Full Text] [Related]

  • 97.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 98. Transmission of human immunodeficiency virus Type-1 by fresh-frozen plasma treated with methylene blue and light.
    Álvarez M, Luis-Hidalgo M, Bracho MA, Blanquer A, Larrea L, Villalba J, Puig N, Planelles D, Montoro J, González-Candelas F, Roig R.
    Transfusion; 2016 Apr; 56(4):831-6. PubMed ID: 26585542
    [Abstract] [Full Text] [Related]

  • 99. Hemostatic Activity of Canine Never-Frozen Liquid Plasma Collected for Transfusion.
    Proverbio D, Perego R, Baggiani L, Spada E.
    Front Vet Sci; 2022 Apr; 9():731617. PubMed ID: 35242834
    [Abstract] [Full Text] [Related]

  • 100. Prolonged (post-thaw) shelf life of -80°C frozen AB apheresis plasma.
    Rijnhout TWH, Noorman F, De Kort B, Zoodsma M, Hoencamp R.
    Transfusion; 2020 Aug; 60(8):1846-1855. PubMed ID: 32692441
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.